SCHEMBL7604401

SCHEMBL7604401

CC(C)(Cc1ccc(-c2ccccc2)cc1)NC[C@H](O)COc1cc(-c2ccc(C(=O)O)cc2)ccc1C#N

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CASR P41180 17/20 0.60
SLC6A2 P23975 6/20 0.60
SLC6A4 P31645 6/20 0.60
SLC6A3 Q01959 6/20 0.60
KCNH2 Q12809 6/20 0.60
CYP2D6 P10635 6/20 0.60
ADRB2 P07550 4/20 0.60
ADRB3 P13945 2/20 0.60
HTR1A P08908 1/20 0.50
ADRA2A P08913 1/20 0.50
ADRA2B P18089 1/20 0.50
MAOA P21397 1/20 0.50
HTR2B P41595 1/20 0.50
ADRB1 P08588 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7604407 1.00 CASR (0.60) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7604390 1.00 CASR (0.60) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7600782 0.95 CASR (0.57) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7600794 0.95 CASR (0.57) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7600787 0.95 CASR (0.57) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7602953 0.94 CASR (0.60) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7602969 0.94 CASR (0.60) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7602962 0.94 CASR (0.60) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7604378 0.94 CASR (0.54) CASRSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7604380 0.94 CASR (0.54) CASRSLC6A2SLC6A4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417215-B1 USE AS CALCIUM RECEPTOR ANTAGONISTS. EXTRACELLULAR CA.SUP.2+ INHIBITS THE SECRETION OF PARATHYROID HORMONE (?PTH?) FROM PARATHYROID CELLS, SMITHKLINE BEECHAM CORPORATION 2002-07-09 US disclosed